{
    "clinical_study": {
        "@rank": "28471", 
        "arm_group": {
            "arm_group_label": "Incident peritoneal dialysis patients", 
            "description": "Patients with chronic kidney disease incident to peritoneal dialysis treatment"
        }, 
        "brief_summary": {
            "textblock": "The primary objective is to analyze peritonitis rate and peritonitis bacteriology as risk\n      factors for loss of residual renal function, technique failure and mortality in chronic\n      kidney disease patients.\n\n      Secondary objectives are: To know the current rate of peritonitis in peritoneal dialysis\n      population and to understand the bacteriological profile of peritonitis.\n\n      To know the rate and risk factors other than peritonitis involved in the loss of residual\n      renal function.\n\n      To analyze the utility of alternative diagnostic tests, such as reagent strips, for early\n      detection of peritonitis when traditional tests are not available.\n\n      To analyze the simultaneous measurement of serum creatinine and cystatin-C as alternative\n      measurements of peritoneal clearance and residual renal function."
        }, 
        "brief_title": "Peritonitis and Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Loss of Residual Renal Function", 
            "Technique Failure in Peritoneal Dialysis"
        ], 
        "condition_browse": {
            "mesh_term": "Peritonitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:Inclusion criteria include: adult patients with signed informed consent\n        given; there should not be selection for age, gender, primary cause of renal disease.\n\n        -\n\n        Exclusion Criteria:Patients will not be included if they were previously in hemodialysis\n        or received renal transplant. Patients will also be excluded if they are on\n        immunosuppressive therapy, have diagnosis of cancer, or are seropositive for HIV or\n        hepatitis.\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients starting PD as the first dialysis treatment will be considered. Recruitment\n        will take place over a six-months period in hospitals belonging to the Instituto Mexicano\n        de Seguro Social. Inclusion criteria include: adult patients with signed informed consent\n        given; there should not be selection for age, gender, primary cause of renal disease.\n        Patients will not be included if they were previously in hemodialysis or received renal\n        transplant. Patients will also be excluded if they are on immunosuppressive therapy, have\n        diagnosis of cancer, or are seropositive for HIV or hepatitis."
            }
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01977716", 
            "org_study_id": "R-2013-785-069"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Peritonitis", 
            "loss of residual renal function", 
            "technique survival"
        ], 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mexico City", 
                    "country": "Mexico", 
                    "state": "DF", 
                    "zip": "06722"
                }, 
                "name": "Unidad de Investigaci\u00f3n M\u00e9dica en Enfermedades Nefrol\u00f3gicas, Instituto Mexicano del Seguro Social"
            }, 
            "investigator": [
                {
                    "last_name": "Ramon Paniagua, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Catarina Munguia-Miranda, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Maria de Jesus Ventura-Garcia, MSc", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Role of Peritonitis in the Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients", 
        "other_outcome": {
            "measure": "Death", 
            "safety_issue": "Yes", 
            "time_frame": "25 months"
        }, 
        "overall_contact": {
            "email": "jrpaniaguas@gmail.com", 
            "last_name": "Ramon Paniagua, MD, PhD", 
            "phone": "+52-55-56276900", 
            "phone_ext": "21371"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Mexico: Coordinaci\u00f3n de Investigaci\u00f3n en Salud", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Loss of residual renal function", 
                "safety_issue": "Yes", 
                "time_frame": "25 months"
            }, 
            {
                "description": "Shift to hemodialysis", 
                "measure": "Technique (peritoneal dialysis) failure", 
                "safety_issue": "Yes", 
                "time_frame": "25 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01977716"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Coordinaci\u00f3n de Investigaci\u00f3n en Salud, Mexico", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Coordinaci\u00f3n de Investigaci\u00f3n en Salud, Mexico", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}